Cisplatin

CD44 molecule (Indian blood group) ; Homo sapiens







66 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34551150 Melatonin enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44high OSCC cells. 2022 Mar 4
2 35398618 Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration. 2022 May 1
3 32700607 Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells. 2021 1
4 33610575 Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade. 2021 May 1 1
5 33919109 Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin. 2021 Apr 21 1
6 34076552 Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells. 2021 Sep 1
7 34123574 Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. 2021 Jun 1 1
8 34400945 Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549. 2021 Winter 2
9 34680456 NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44. 2021 Sep 28 1
10 31953176 Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells. 2020 Apr 15 4
11 32151664 Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy. 2020 Apr 30 1
12 32244823 CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells. 2020 Apr 1 1
13 32252293 Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells. 2020 Apr 2 2
14 32527702 MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes. 2020 Sep 1
15 30077625 Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance. 2019 May 2
16 30485589 Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. 2019 Feb 3
17 31781681 Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages. 2019 2
18 29171106 Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. 2018 Feb 3
19 29385995 Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer. 2018 Jan 31 2
20 29515788 CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells. 2018 Feb 9 3
21 30182373 EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. 2018 Dec 1
22 30448176 CD44v-dependent upregulation of xCT is involved in the acquisition of cisplatin-resistance in human lung cancer A549 cells. 2018 Dec 9 1
23 26910918 Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy. 2017 Jan 31 1
24 27244887 Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer. 2017 May 9 1
25 27999837 Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. 2017 Jan 5 1
26 28107698 The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy. 2017 Apr 2
27 28466360 Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407). 2017 Nov 1
28 28903181 Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. 2017 Nov 1
29 28961534 Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. 2017 Dec 1
30 29029509 Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations. 2017 Sep 12 1
31 29110853 CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment. 2017 Nov 1
32 27040816 Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines. 2016 May 28 1
33 26117979 Innovative therapy of ovarian cancer based on overexpression of CD44 receptor. 2015 May 1
34 26338199 Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro. 2015 Sep 4 1
35 26349992 Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells. 2015 Aug 2
36 26448751 Carboxymethyl Hyaluronan-Stabilized Nanoparticles for Anticancer Drug Delivery. 2015 1
37 26609473 LIN28B suppresses microRNA let-7b expression to promote CD44+/LIN28B+ human pancreatic cancer stem cell proliferation and invasion. 2015 1
38 24423412 Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. 2014 Jan 15 2
39 24606473 Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. 2014 3
40 24612587 Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. 2014 Mar 11 1
41 24681046 A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells. 2014 May 1 3
42 24684961 Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture. 2014 Aug 1
43 24884875 Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. 2014 Apr 30 3
44 24947926 CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. 2014 Aug 1 1
45 25299431 Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44. 2014 Dec 4
46 22473523 Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. 2013 Apr 1
47 22770891 CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits. 2013 Jan 1
48 23265944 CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. 2013 Apr 1
49 23368632 Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. 2013 Jan 31 1
50 23715169 A tissue-engineered gastric cancer model for mechanistic study of anti-tumor drugs. 2013 Aug 1